Kodiak Sciences Inc (KOD)
3.91
-0.03
(-0.76%)
USD |
NASDAQ |
May 07, 09:51
Kodiak Sciences Net Income (Quarterly): -59.52M for Dec. 31, 2023
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -59.52M |
September 30, 2023 | -50.01M |
June 30, 2023 | -80.19M |
March 31, 2023 | -70.78M |
December 31, 2022 | -70.45M |
September 30, 2022 | -77.04M |
June 30, 2022 | -90.63M |
March 31, 2022 | -95.71M |
December 31, 2021 | -93.16M |
September 30, 2021 | -67.53M |
June 30, 2021 | -55.85M |
March 31, 2021 | -50.45M |
December 31, 2020 | -46.58M |
Date | Value |
---|---|
September 30, 2020 | -36.12M |
June 30, 2020 | -26.00M |
March 31, 2020 | -24.39M |
December 31, 2019 | -15.62M |
September 30, 2019 | -12.38M |
June 30, 2019 | -11.38M |
March 31, 2019 | -7.984M |
December 31, 2018 | -14.66M |
September 30, 2018 | -10.45M |
June 30, 2018 | -7.409M |
March 31, 2018 | -8.92M |
December 31, 2017 | -11.57M |
September 30, 2017 | -4.583M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-95.71M
Minimum
Mar 2022
-11.38M
Maximum
Jun 2019
-54.41M
Average
-55.85M
Median
Jun 2021
Net Income (Quarterly) Benchmarks
Avalo Therapeutics Inc | -8.168M |
Regeneron Pharmaceuticals Inc | 722.00M |
iBio Inc | -8.211M |
Puma Biotechnology Inc | -4.815M |
Dare Bioscience Inc | -5.058M |
Net Income (Quarterly) Related Metrics
Total Expenses (Quarterly) | 63.37M |
EPS Diluted (Quarterly) | -1.13 |
Enterprise Value | -78.52M |
Earnings Yield | -126.9% |